Green, Daniel M <br/><br/>
Augmentation of Therapy for Combined Loss of Heterozygosity 1p and 16q in Favorable Histology Wilms Tumor.  [electronic resource] 

 -  Journal of clinical oncology : official journal of the American Society of Clinical Oncology  03 2020 
 - 772-773 p.  digital 
<br/><br/> Publication Type: Letter; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Comment 
<br/><br/><label>ISSN: </label>1527-7755 
<br/><br/><label>Standard No.: </label>10.1200/JCO.19.02479  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Child<br/>Heterozygote<br/>Humans<br/>Kidney Neoplasms--drug therapy<br/>Loss of Heterozygosity<br/>Wilms Tumor--genetics